| Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144) |
|---|
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1045839B1 Novel amines as pharmaceutical agents |
| 03/03/2004 | EP1038874B1 Oxime derivatives and agricultural chemicals containing the same |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699866 For therapy of addiction, anxiety, depression, sexual dysfunction, hypertension, migraine, alzheimer's disease, obesity, emesis, psychosis, analgesia, schizophrenia, parkinson's disease, restless leg syndrome, sleeping disorders |
| 02/26/2004 | WO2004016221A2 Sulfonamides as potassium channel blockers |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | CA2495956A1 Sulfonamides as potassium channel blockers |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696110 Liquid crystalline alkenyl compounds incorporating an heterocyclic five-membered ring |
| 02/19/2004 | WO2004015025A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 02/19/2004 | WO2004014881A2 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014370A2 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014357A2 Therapeutic use of aryl amino acid derivatives |
| 02/19/2004 | US20040034242 Compounds containing a specific branched chain end terminal group, which is isopropyl, sec.-butyl, or tert.-butyl; a polar leading group, and long chain aliphatic, non-cyclic, saturated or nonsaturated linking groups |
| 02/19/2004 | US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin |
| 02/19/2004 | CA2495120A1 Oxadiazoles as modulators of metabotropic glutamate receptor-5 |
| 02/19/2004 | CA2495108A1 Therapeutic use of aryl amino acid derivatives |
| 02/19/2004 | CA2494086A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 02/19/2004 | CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/18/2004 | EP1389191A1 Heterocyclyl phenyl benzyl ethers used as fungicides |
| 02/18/2004 | EP1389185A2 Aminoalcohol derivatives |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2002083863A3 Thiazole and other heterocyclic ligands and use thereof |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029913 Halogenated selective androgen receptor modulators and methods of use thereof |
| 02/12/2004 | US20040029886 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/11/2004 | EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity |
| 02/11/2004 | CN1474805A 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/10/2004 | US6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 02/05/2004 | US20040024215 Such as 4'-trifluoromethyl-biphenyl-2-carboxylic acid(4-(4-(alpha-methyl-benzyl)-piperazin-1-yl)-phenyl)-amide; apoprotein B-100 (apoB-100) and microsomal triglyceride transfer protein (MTP) |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | DE10231627A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6686065 [5]-helicene and dibenzofluorene materials for use in organic light emitting devices |
| 01/29/2004 | WO2004009533A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | US20040019215 Reacting carboxy nitriles with hydroxylamine salts, then anhydriding the chemical intermediates and cyclization to form nitrogen compounds such as ethyl 5-(2-((t-butoxy)carbonyl amino)ethyl)-1,2,4-oxadiazole-3-carboxylate |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019017 Caspase inhibitor prodrugs |
| 01/29/2004 | CA2493457A1 Acetylamino benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 01/28/2004 | EP1383749A1 Arylsulfonamides as antiviral agents |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383729A1 Peptide deformylase inhibitors |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/27/2004 | US6683215 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/27/2004 | US6682782 Organic compound having an acetylene group, vacuum deposition polymerization thereof, deposited polymerized thin film, and electroluminescence device containing same |
| 01/22/2004 | WO2004007455A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | US20040014975 For contraception, treatment of hormone-related (aging) conditions, and sexual dysfunction |
| 01/22/2004 | US20040014741 Dietetics; antidiabetic agents; antiinflammatory agents |
| 01/22/2004 | CA2493374A1 Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| 01/21/2004 | EP1381590A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 01/21/2004 | EP0811002B1 Benzylpiperidines and piperazines as muscarinic antagonists |
| 01/21/2004 | CN1469876A Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 01/15/2004 | WO2004005229A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | WO2004004655A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | US20040009979 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/14/2004 | EP1380571A1 Compounds useful for treating allergic and inflammatory diseases |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | CN1468211A Nitroso diphenylamine derivatives |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677277 Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides |
| 01/08/2004 | WO2004003102A2 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use |
| 01/08/2004 | WO2004002491A1 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 01/08/2004 | WO2004002462A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | US20040006073 Method of treating attention deficit hyperactivity disorder |
| 01/08/2004 | US20040006050 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/08/2004 | CA2488566A1 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 01/08/2004 | CA2488525A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 01/07/2004 | EP1377559A2 Rxr activating molecules |
| 01/07/2004 | EP1377543A1 Oxalic acid derivatives |
| 01/07/2004 | CN1133636C Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 01/07/2004 | CN1133626C Diclofenac coupled derivative and its synthesizing process and inflammation relieving action |
| 01/02/2004 | EP1373264A1 3-heterocyclylpropanohydroxamic acid as procollagen c-proteinase inhibitors |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373231A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2004000785A2 Phenyloxyalkanonic acid derivatives as hppar activators |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/24/2003 | CN1131855C 1－取代－1－氨基甲基－环烷衍生物(=加巴喷丁类似物)、其制备及其在治疗神经病方面的用途 L-amino-1-substituted methyl - naphthenic derivative (= gabapentin analogs), their preparation and their use in the treatment of neuropathy |